CA2173844A1 - Chelateurs n-alkylpeptidiques, leurs complexes metalliques avec des radionucleides, procedes pour leur preparation et compositions radiopharmaceutiques contenant ces composes - Google Patents

Chelateurs n-alkylpeptidiques, leurs complexes metalliques avec des radionucleides, procedes pour leur preparation et compositions radiopharmaceutiques contenant ces composes

Info

Publication number
CA2173844A1
CA2173844A1 CA002173844A CA2173844A CA2173844A1 CA 2173844 A1 CA2173844 A1 CA 2173844A1 CA 002173844 A CA002173844 A CA 002173844A CA 2173844 A CA2173844 A CA 2173844A CA 2173844 A1 CA2173844 A1 CA 2173844A1
Authority
CA
Canada
Prior art keywords
general formula
group
compounds
residue
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002173844A
Other languages
English (en)
Inventor
Hartmut Spies
Paul Eberhard Schulze
Bernd Noll
Steffi Noll
Ludger Dinkelborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2173844A1 publication Critical patent/CA2173844A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/26—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des chélateurs N-alkylpeptidiques, leurs complexes métalliques avec des radionucléides, des procédés pour leur préparation et des compositions radiopharmaceutiques contenant ces composés. L'invention concerne également des produits radiopharmaceutiques contenant ces chélates sous une forme complexée avec des métaux, des trousses de diagnostic dans lesquelles le chélate peut se présenter sous une forme non complexée et être complexé par addition d'ions technétium ou rhénium, et elle concerne également l'utilisation de ces préparations à des fins diagnostiques et thérapeutiques.
CA002173844A 1993-11-01 1994-10-27 Chelateurs n-alkylpeptidiques, leurs complexes metalliques avec des radionucleides, procedes pour leur preparation et compositions radiopharmaceutiques contenant ces composes Abandoned CA2173844A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4337600A DE4337600A1 (de) 1993-11-01 1993-11-01 N-Alkyl-Peptidchelatbildner, deren Metallkomplexe mit Radionukliden, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Zusammesetzungen
DEP4337600.2 1993-11-01

Publications (1)

Publication Number Publication Date
CA2173844A1 true CA2173844A1 (fr) 1995-05-11

Family

ID=6501750

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002173844A Abandoned CA2173844A1 (fr) 1993-11-01 1994-10-27 Chelateurs n-alkylpeptidiques, leurs complexes metalliques avec des radionucleides, procedes pour leur preparation et compositions radiopharmaceutiques contenant ces composes

Country Status (11)

Country Link
EP (1) EP0726909A1 (fr)
JP (1) JPH09508351A (fr)
KR (1) KR960705842A (fr)
CN (1) CN1134158A (fr)
AU (1) AU681919B2 (fr)
CA (1) CA2173844A1 (fr)
DE (1) DE4337600A1 (fr)
HU (1) HUT74881A (fr)
NO (1) NO961743L (fr)
WO (1) WO1995012610A1 (fr)
ZA (1) ZA948411B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US6162378A (en) * 1999-02-25 2000-12-19 3D Systems, Inc. Method and apparatus for variably controlling the temperature in a selective deposition modeling environment
US6171578B1 (en) 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi
CN100494182C (zh) * 2000-05-12 2009-06-03 基酶有限公司 肿瘤坏死α因子信号的调节因子

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811340B (en) * 1980-06-09 1982-03-31 Morton Norwich Products Inc N-(cycloalkyl)amino acid compounds
WO1992019274A1 (fr) * 1991-05-08 1992-11-12 Mallinckrodt Medical, Inc. Chelates de technetium utilisables pour l'examen de la fonction renale
JPH0570484A (ja) * 1991-09-12 1993-03-23 Hitachi Chem Co Ltd ペプチドおよびその塩
WO1993015771A1 (fr) * 1992-02-06 1993-08-19 Mallinckrodt Medical, Inc. Ligands permettant d'ameliorer la cinetique de formation d'agents chelateurs
ATE196094T1 (de) * 1992-05-21 2000-09-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
DE4311021A1 (de) * 1993-03-31 1994-10-27 Diagnostikforschung Inst Bifunktionelle Chelatbildner, deren Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Mittel

Also Published As

Publication number Publication date
ZA948411B (en) 1995-06-30
DE4337600A1 (de) 1995-05-04
KR960705842A (ko) 1996-11-08
EP0726909A1 (fr) 1996-08-21
NO961743D0 (no) 1996-04-30
CN1134158A (zh) 1996-10-23
WO1995012610A1 (fr) 1995-05-11
HUT74881A (en) 1997-02-28
AU681919B2 (en) 1997-09-11
JPH09508351A (ja) 1997-08-26
AU8103894A (en) 1995-05-23
HU9601140D0 (en) 1996-07-29
NO961743L (no) 1996-04-30

Similar Documents

Publication Publication Date Title
EP0108406B1 (fr) Agents de chélation bifonctionnels
CA2145983C (fr) Substance proteinique chimiotactique de monocyte, marquee, et son utilisation en medecine
EP0831938B1 (fr) Compositions de peptides radiomarques pour le ciblage specifique d'un site
JP2000515514A (ja) 放射性金属元素結合ペプチドの類似化合物
AU634645B2 (en) Chelating compounds and their use
JPH02184698A (ja) ペプチド誘導体
JPH09503496A (ja) ヒドラジノ型ｎ▲下２▼ｓ▲下２▼キレート化剤
JPH04505022A (ja) 診断または治療に使用する放射性同位元素で標識した蛋白質
CA2156620A1 (fr) Agents de chelation de type xn1s1o pour isotopes radioactifs; leurs complexes metalliques et leur utilisation a des fins diagnostiques et therapeutiques
EP0607103A2 (fr) Analogues de somatostatine contenants des agents de chélation et leur compositions radio-marquées
CA2232340A1 (fr) Agents de formation de chelates de nicotinamide bifonctionnels du type n2s2 pour isotopes radioactifs
US5618513A (en) Method for preparing radiolabeled peptides
CA2232391A1 (fr) Agents de chelation amidosulfoniques sulfures bifonctionnels du type xsns pour isotopes radioactifs
AU6501594A (en) Bifunctional chelators and their use in radiopharmaceuticals
CA2173844A1 (fr) Chelateurs n-alkylpeptidiques, leurs complexes metalliques avec des radionucleides, procedes pour leur preparation et compositions radiopharmaceutiques contenant ces composes
CA2232315A1 (fr) Agents de chelation amidosulfoniques sulfures bifonctionnels du type s2ny pour isotopes radioactifs
US5961954A (en) Chealators of type XN1 S1 X1 for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
US6143275A (en) Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
DE4425781A1 (de) Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel
US6132697A (en) Radiopharmaceutical compositions capable of localizing at sites of thrombus
CA2151099A1 (fr) Peptide possedant de l'affinite pour les tumeurs; agent diagnostic radioactif et agent therapeutique radioactif renfermant ce peptide
JP3844138B2 (ja) 隔離された画像化剤
PL163432B1 (pl) Sposób wytwarzania nowych pochodnych peptydu somatostatyny PL PL PL PL

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead